Eye drop recall issued over sterility concerns

Eye drop recall issued over sterility concerns nationwide

The eye drop recall issued over sterility concerns now affects more than 3 million bottles of products sold nationwide.

The recall involves eye drops manufactured by K.C. Pharmaceuticals and has been classified as a Class II FDA recall, meaning the products could cause temporary or reversible health problems, according to FDA recall safety information.

Officials say the issue stems from a lack of sterility assurance in eye drop production, raising concerns about potential contamination.

Eye drop recall issued over sterility concerns at major retailers

The eye drop recall issued over sterility concerns includes store-brand products sold at Walmart, CVS, Walgreens, Kroger, and Target.

More than 3.1 million bottles across multiple brands are impacted, including artificial tears, dry eye relief drops, and redness relief eye drops.

Health officials warn the products may contain infection-causing bacteria in eye drops, which can pose a higher risk for people with sensitive eyes or weakened immune systems, according to FOX 11 Los Angeles recall report.

Most affected products carry expiration dates ranging from April through October 2026.

Eye drop recall issued over sterility concerns with consumer warning

The eye drop recall issued over sterility concerns includes urgent guidance for consumers to take immediate action.

Consumers are urged to stop using recalled eye drops immediately, check packaging for specific lot codes, and return products for a full refund.

Anyone experiencing symptoms should seek medical attention and report issues through the FDA MedWatch safety reporting system.

Officials say acting quickly can help prevent eye infections linked to contaminated products and reduce further risk.

🔴 MORE RADIO NEWS